Bacterial Culture Filtrate Protein Concentration using an Ultrafiltration Device
JoVE Encyclopedia of Experiments
Immunology
0 views • 2:49 min • July 8th, 2025
Take a large-volume centrifugal filter device containing vertical regenerated cellulose membranes of a suitable pore size.
Add buffer and centrifuge. Remove the flow-through containing membrane humectant.
Load the device with bacterial culture filtrate protein, or CFP, encompassing soluble proteins and extracellular vesicles, or EVs – nanosized lipid-bound structures containing biomolecules secreted by bacteria.
During centrifugation, CFP passes tangentially across the membranes via centrifugal force.
Biomolecules smaller than the membrane's pores pass through with culture fluid, while larger ones, such as EVs, pass over the membrane surface, minimizing membrane clogging.
The filter concentrates the CFP into a minimum device volume, aided by its dead-stop volume to prevent biomolecule drying.
Add buffer and centrifuge.
The buffer replaces residual media components, creating an isotonic environment for CFP biomolecules and maintaining their integrity.
Place the concentrate cup over the filter cup, invert, and centrifuge. Recover the concentrated CFP retentate for further analysis.
To begin, prepare a 100 kilodalton molecular weight cutoff centrifugal filter by adding the full volume capacity of PBS. Centrifuge for five minutes at 2,800 times g at 4 degrees Celsius. Discard the flow through, and any remaining PBS, and fill the sample chamber with Mtb CFP to its maximum capacity. Centrifuge at 2,800 times g at 4 degrees Celsius until the volume has reduced to the minimum volume of the ultrafiltration device. Repeat as necessary until the entire sample has been reduced sufficiently.
Add 1x PBS to the filter unit containing the concentrate up to the total device capacity. Reduce the volume as described before and repeat this step five times to ensure complete washing and buffer exchange. Then, recover the 100 kilodalton-concentrated CFP retentate, or 100R, according to the ultrafiltration device specifications. Wash the filter with a minimal volume of 1x PBS at least three times, and pull the wash with the 100R to maximize the recovery.
Overview
This article describes a method for concentrating bacterial culture filtrate proteins (CFP) using a large-volume centrifugal filter device. The process involves centrifugation to separate biomolecules based on size, allowing for the recovery of extracellular vesicles (EVs) and soluble proteins.
Key Study Components
Area of Science
- Microbiology
- Biochemistry
- Biotechnology
Background
- Bacterial culture filtrate contains valuable biomolecules.
- Extracellular vesicles (EVs) are important for intercellular communication.
- Concentration of CFP is essential for downstream applications.
- Ultrafiltration techniques can enhance biomolecule recovery.
Purpose of Study
- To develop a reliable method for concentrating bacterial CFP.
- To minimize membrane clogging during filtration.
- To maintain the integrity of biomolecules during the concentration process.
Methods Used
- Use of a centrifugal filter device with regenerated cellulose membranes.
- Centrifugation to separate biomolecules based on size.
- Buffer exchange to create an isotonic environment.
- Multiple washing steps to maximize recovery of concentrated CFP.
Main Results
- Successful concentration of CFP with minimal loss of biomolecules.
- Effective separation of EVs from soluble proteins.
- Demonstrated efficiency of the ultrafiltration method.
- Maintained integrity of concentrated biomolecules throughout the process.
Conclusions
- The described method is effective for concentrating bacterial CFP.
- Ultrafiltration can be optimized for various applications.
- This technique can facilitate further analysis of bacterial biomolecules.
Frequently Asked Questions
Executive Industry Relevance
Efficient concentration of bacterial culture filtrate proteins, including extracellular vesicles, is critical for enabling robust biomarker discovery and downstream translational research. Ultrafiltration-based workflows support reproducible sample preparation, which is essential for high-confidence target validation and assay development in infectious disease portfolios. This capability strengthens the reliability of early-stage biological insights and facilitates risk-adjusted progression through the discovery pipeline.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables isolation of extracellular vesicles for mechanistic studies and target validation.
- Supports interrogation of secreted bacterial proteins relevant to disease pathways.
- Facilitates biological de-risking by providing concentrated, intact biomolecules for functional assays.
Screening & Assay Development
- Delivers reproducible, concentrated protein samples for standardized assay input.
- Improves assay sensitivity and quantitative output by minimizing sample variability.
- Prepares validated biological material for scalable screening workflows.
Translational & Preclinical Research
- Enables enrichment of diagnostic markers for translational biomarker studies.
- Maintains biomolecule integrity for continuity from discovery to preclinical validation.
- Supports risk-adjusted advancement by providing high-quality input for downstream analyses.
Pipeline & Workflow Integration
This ultrafiltration protocol integrates at the interface of early discovery and assay development, providing concentrated, high-integrity samples for both mechanistic studies and translational research.
- Discovery Biology: Concentrates secreted proteins and vesicles to support hypothesis-driven target validation.
- Screening: Supplies reproducible, quantitative samples for assay standardization and compound evaluation.
- Analytics: Enables quantitative measurement of protein and vesicle content for comparative analyses.
- Translational Research: Aligns with biomarker enrichment needs for preclinical and diagnostic studies.
- Enterprise Reuse: Provides a standardized, scalable sample preparation workflow for diverse R&D programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in early-stage research.
- Operational Value: Delivers standardized, reproducible, and scalable sample preparation.
- Strategic Value: Improves go/no-go decision quality and capital efficiency by reducing sample variability.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of infectious disease assets.
Implementation Considerations
- Requires expertise in protein and vesicle handling to maintain sample integrity.
- Needs access to centrifugal ultrafiltration devices and compatible analytical infrastructure.
- Demands cross-team standardization for reproducible sample preparation.
- Adaptable to various bacterial systems with appropriate membrane selection.
- Limited by device capacity and potential sample loss if not optimized.
Biopharma FAQs
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Related Videos
0 Views
Modeling Tuberculosis in Mycobacterium marinum Infected Adult Zebrafish
Related Videos
0 Views
Isolation and Characterization of Extracellular Vesicles Produced by Iron-limited Mycobacteria
Related Videos
0 Views
Isolation and Enrichment of Outer Membrane-Derived Extracellular Vesicles from Bacteria
Related Videos
0 Views
Selective Purification of a Bacterial Protein by Negative Ion-Exchange Chromatography
Related Videos
0 Views
A Size Exclusion Chromatography Technique to Purify Mycobacterial Extracellular Vesicles
Related Videos
0 Views
Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains
Related Videos
0 Views
Essential Metal Uptake in Gram-negative Bacteria: X-ray Fluorescence, Radioisotopes, and Cell Fractionation
Related Videos
0 Views
Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria
Related Videos
0 Views
Concentration of Virus Particles from Environmental Water and Wastewater Samples Using Skimmed Milk Flocculation and Ultrafiltration
Related Videos
0 Views
Last updated: 22 August 2026